| 1 |
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Joana Torres et al. · Journal of Crohn s and Colitis
Open access |
2 Nov 2019 |
1,378 |
| 2 |
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
Michel Adamina et al. · Journal of Crohn s and Colitis
Open access |
15 Nov 2019 |
1,128 |
| 3 |
Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke: The German Stroke Data Bank
Armin Grau, Christian Weimar, Florian Buggle et al. · Stroke
|
Nov 2001 |
1,012 |
| 4 |
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
Gregory J. del Zoppo, Klaus Poeck, Michael S. Pessin et al. · Annals of Neurology
|
Jul 1992 |
1,004 |
| 5 |
Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
Alessandro Maria Vannucchi, Jean‐Jacques Kiladjian, Martin Grießhammer et al. · New England Journal of Medicine
Open access |
28 Jan 2015 |
893 |
| 6 |
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
Hans‐Christoph Diener et al. · New England Journal of Medicine
Open access |
15 May 2019 |
833 |
| 7 |
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial
Ulrike Leiter, Rudolf Stadler, Cornelia Mauch et al. · The Lancet Oncology
|
6 May 2016 |
710 |
| 8 |
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
Henry Miles Prince et al. · The Lancet
|
7 Jun 2017 |
593 |
| 9 |
European Stroke Organisation (ESO) – European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE)
Guillaume Turc, Pervinder Bhogal, Urs Fischer et al. · European Stroke Journal
Open access |
26 Feb 2019 |
584 |
| 10 |
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
Tiziano Barbui et al. · Leukemia
Open access |
27 Feb 2018 |
569 |
| 11 |
Anticoagulant Reversal, Blood Pressure Levels, and Anticoagulant Resumption in Patients With Anticoagulation-Related Intracerebral Hemorrhage
Joji B. Kuramatsu et al. · JAMA
|
24 Feb 2015 |
568 |
| 12 |
Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity
Christian Joerg Braun et al. · Science Translational Medicine
Open access |
12 Mar 2014 |
561 |
| 13 |
European Stroke Organisation (ESO)- European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke
Guillaume Turc, Pervinder Bhogal, Urs Fischer et al. · Journal of NeuroInterventional Surgery
|
31 May 2019 |
477 |
| 14 |
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
Robyn M. Emanuel et al. · Journal of Clinical Oncology
Open access |
16 Oct 2012 |
465 |
| 15 |
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
Franz Trautinger, Johanna Eder, Chalid Assaf et al. · European Journal of Cancer
Open access |
31 Mar 2017 |
452 |
| 16 |
Self-Expanding Metal Stents for Gastroduodenal Malignancies: Systematic Review of their Clinical Effectiveness
Arno Josef Dormann, Søren Meisner, Nathalie Verin et al. · Endoscopy
|
Jun 2004 |
443 |
| 17 |
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome
Franz Trautinger, Robert Knobler, Rein Willemze et al. · European Journal of Cancer
Open access |
31 Mar 2006 |
417 |
| 18 |
Imaging of acute stroke
Keith W. Muir, Alastair Mitchell Buchan, Rüdiger von Kummer et al. · The Lancet Neurology
|
18 Aug 2006 |
366 |
| 19 |
Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry
Mark J. Alberts, Deepak L. Bhatt, Jean Louis Mas et al. · European Heart Journal
Open access |
31 Aug 2009 |
333 |
| 20 |
European Stroke Organisation and European Society for Swallowing Disorders guideline for the diagnosis and treatment of post-stroke dysphagia
Rainer Dziewas, Emilia Michou, Michaela Trapl‐Grundschober et al. · European Stroke Journal
Open access |
Sep 2021 |
324 |
| 21 |
The REduction of Atherothrombosis for Continued Health (REACH) Registry: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design
E. Magnus Ohman, Deepak L. Bhatt, Philippe Gabríel Steg et al. · American Heart Journal
|
29 Mar 2006 |
309 |
| 22 |
Hemoadsorption by CytoSorb in septic patients: a case series
Klaus Kogelmann, Dominik Jarczak, Morten Scheller et al. · Critical Care
Open access |
21 Mar 2017 |
304 |
| 23 |
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
Richard F. Schlenk et al. · Blood
Open access |
18 Dec 2018 |
290 |
| 24 |
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
Nicolaus Martin Kröger et al. · Leukemia
|
21 Aug 2015 |
278 |
| 25 |
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference
Giovanni Barosi, Gunnar Birgegård, Guido Finazzi et al. · Blood
Open access |
10 Mar 2009 |
267 |
| 26 |
Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study
Francesco Passamonti, Martin Grießhammer, Francesca Palandri et al. · The Lancet Oncology
|
Dec 2016 |
260 |
| 27 |
Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis
Shinya Goto, Deepak L. Bhatt, Joachim A. Rother et al. · American Heart Journal
|
24 Sep 2008 |
260 |
| 28 |
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry
P. Cacoub, Maria Teresa B. Abola, Iris Baumgärtner et al. · Atherosclerosis
|
Nov 2008 |
256 |
| 29 |
Development of Type 1 Diabetes despite Severe Hereditary B-Cell Deficiency
Stéphan Martin, Dorothea Wolf-Eichbaum, Gaby Duinkerken et al. · New England Journal of Medicine
Open access |
4 Oct 2001 |
253 |
| 30 |
Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: A prospective multicenter observational study
Götz Thomalla, Frank Hartmann, Eric Jüettler et al. · Annals of Neurology
|
23 Sep 2010 |
250 |
| 31 |
An International Model to Predict Recurrent Cardiovascular Disease
Peter W.F. Wilson, Ralph B. D’Agostino, Deepak L. Bhatt et al. · The American Journal of Medicine
Open access |
20 Jun 2012 |
249 |
| 32 |
European Guideline on IgG4‐related digestive disease – UEG and SGF evidence‐based recommendations
Matthias J. Löhr et al. · United European Gastroenterology Journal
Open access |
18 Jun 2020 |
248 |
| 33 |
Guidelines on the use of extracorporeal photopheresis
Robert Knobler et al. · Journal of the European Academy of Dermatology and Venereology
Open access |
19 Dec 2013 |
221 |
| 34 |
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
Hans‐Peter Tony et al. · Arthritis Research & Therapy
Open access |
13 May 2011 |
212 |
| 35 |
Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial
Brett G.M. Hughes, E. Munoz-Couselo, Laurent Mortier et al. · Annals of Oncology
Open access |
20 Jul 2021 |
208 |
| 36 |
Leukoaraiosis Is a Risk Factor for Symptomatic Intracerebral Hemorrhage After Thrombolysis for Acute Stroke
Tobias Neumann‐Haefelin, Silke Hoelig, Joachim Berkefeld et al. · Stroke
Open access |
25 Aug 2006 |
201 |
| 37 |
Assessment of Functioning and Disability After Ischemic Stroke
Christian Weimar, Tobias Kurth, Klaus Kraywinkel et al. · Stroke
Open access |
Aug 2002 |
199 |
| 38 |
Cost‐of‐illness of chronic leg ulcers in Germany
Sandra Purwins, Katharina Herberger, E. Sebastian Debus et al. · International Wound Journal
Open access |
Apr 2010 |
197 |
| 39 |
Surgical and medical management of patients with massive cerebellar infarctions: results of the German-Austrian Cerebellar Infarction Study
Marek Jauß, Don Krieger, Claus R. Hornig et al. · Journal of Neurology
|
29 Apr 1999 |
194 |
| 40 |
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data
Götz Thomalla et al. · The Lancet
ReviewOpen access815 authors |
Nov 2020 |
192 |
| 41 |
The Essen Stroke Risk Score Predicts Recurrent Cardiovascular Events
Christian Weimar, Hans‐Christoph Diener, Mark J. Alberts et al. · Stroke
|
20 Nov 2008 |
192 |
| 42 |
Vedolizumab induction therapy for inflammatory bowel disease in clinical practice – a nationwide consecutive German cohort study
Daniel C. Baumgart, Bernd Bokemeyer, Attyla Drabik et al. · Alimentary Pharmacology & Therapeutics
|
Apr 2016 |
189 |
| 43 |
Degradation of cationic and anionic dyes in coagulation–flocculation process using bi-functionalized silica hybrid with aluminum-ferric as auxiliary agent
Yen-Yie Lau, Yee‐Shian Wong, Tjoon Tow Teng et al. · RSC Advances
|
2015 |
187 |
| 44 |
Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage
Joji B. Kuramatsu et al. · JAMA
Open access |
8 Oct 2019 |
186 |
| 45 |
Randomised trial of single and repeated fibrin glue compared with injection of polidocanol in treatment of bleeding peptic ulcer
Paul J. Rutgeerts, Erik A.J. Rauws, Pål Wara et al. · The Lancet
|
Sep 1997 |
186 |
| 46 |
Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
DGCIN – German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group, Jens Atzpodien, E. Schmitt et al. · British Journal of Cancer
Open access |
Mar 2005 |
186 |
| 47 |
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban
Thorsten Steiner, Michael C Böhm, Martin Dichgans et al. · Clinical Research in Cardiology
|
13 May 2013 |
183 |
| 48 |
European Neuroendocrine Tumor Society ( ENETS ) 2023 guidance paper for gastroduodenal neuroendocrine tumours ( NETs) G1–G3
Francesco Panzuto, John Keith Ramage, David Mark Pritchard et al. · Journal of Neuroendocrinology
Open access |
20 May 2023 |
181 |
| 49 |
Risk of Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis in Patients With Acute Ischemic Stroke and High Cerebral Microbleed Burden
Georgios K. Tsivgoulis, Ramin Zand, Aristeidis H. Katsanos et al. · JAMA Neurology
Open access |
18 Apr 2016 |
181 |
| 50 |
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
Elise A. Olsen et al. · Blood
Open access |
11 Nov 2021 |
180 |